rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2011-6-6
|
pubmed:abstractText |
Glioblastoma multiforme is the most common malignant primary tumor of the brain in adults. Standard therapy consists in maximal surgical resection and adjuvant concurrent chemoradiotherapy and adjuvant therapy with temozolomid. This approach improves survival in comparison with postsurgical radiotherapy alone.
|
pubmed:language |
cze
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0862-495X
|
pubmed:author |
pubmed-author:BelanováRR,
pubmed-author:FadrusPP,
pubmed-author:KretJJ,
pubmed-author:LakomýRR,
pubmed-author:LzicarováEE,
pubmed-author:PoprachAA,
pubmed-author:ProcházkováMM,
pubmed-author:SchneiderováMM,
pubmed-author:SikováII,
pubmed-author:SlabýOO,
pubmed-author:SlampaPP,
pubmed-author:SmrckaMM,
pubmed-author:SvobodaMM,
pubmed-author:SvobodaTT,
pubmed-author:VyzulaRR,
pubmed-author:WengLL
|
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
112-20
|
pubmed:meshHeading |
pubmed-meshheading:21644366-Adult,
pubmed-meshheading:21644366-Aged,
pubmed-meshheading:21644366-Brain Neoplasms,
pubmed-meshheading:21644366-Combined Modality Therapy,
pubmed-meshheading:21644366-Female,
pubmed-meshheading:21644366-Glioblastoma,
pubmed-meshheading:21644366-Humans,
pubmed-meshheading:21644366-Karnofsky Performance Status,
pubmed-meshheading:21644366-Male,
pubmed-meshheading:21644366-Middle Aged,
pubmed-meshheading:21644366-Survival Rate,
pubmed-meshheading:21644366-Young Adult
|
pubmed:year |
2011
|
pubmed:articleTitle |
[Multimodal treatment of glioblastoma multiforme: results of 86 consecutive patients diagnosed in period 2003-2009].
|
pubmed:affiliation |
Masaryk?v onkologický ústav, Brno.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|